These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16104623)

  • 21. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EORTC GI group experience with high-dose infusional 5-FU in colorectal cancer.
    Blijham GH
    J Infus Chemother; 1996; 6(3):114-7. PubMed ID: 9229320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
    Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
    Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of acute myocardial infarction during 5-fluorouracil infusion.
    Canale ML; Camerini A; Stroppa S; Porta RP; Caravelli P; Mariani M; Balbarini A; Ricci S
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):835-7. PubMed ID: 17060812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [5-Fluorouracil-induced reticular hyperpigmentation].
    Sanz-Sánchez T; Córdoba S; Jiménez-Ayala B; Borbujo JM
    Actas Dermosifiliogr; 2008 Sep; 99(7):573-4. PubMed ID: 18682175
    [No Abstract]   [Full Text] [Related]  

  • 27. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
    Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
    Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Capsule instead of infusion--new oral chemotherapy option].
    Köhne CH
    Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxic cardiogenic shock in a patient receiving weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin.
    Wang WS; Hsieh RK; Chiou TJ; Liu JH; Fan FS; Yen CC; Tung SL; Chen PM
    Jpn J Clin Oncol; 1998 Sep; 28(9):551-4. PubMed ID: 9793028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angina related to 5-Fluorouracil].
    Luján J; García De Burgos F; Jordán A; García M; Reyes F; Espinosa MD
    Rev Esp Cardiol; 2002 Jul; 55(7):764-7. PubMed ID: 12113705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inotropic agents in the treatment of cardiogenic shock.
    Mueller HS
    World J Surg; 1985 Feb; 9(1):3-10. PubMed ID: 3885584
    [No Abstract]   [Full Text] [Related]  

  • 32. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myocarditis: from chest pain to cardiogenic shock].
    Lemaitre F; Close L; Plein D; Silance PG; Vandenbossche JL
    Ann Cardiol Angeiol (Paris); 2005 Mar; 54(2):97-102. PubMed ID: 15828465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.
    Acharya G; Cruz Carreras MT; Rice TW
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29167217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiotoxicity of 5-fluorouracil. Clinical relevance of palliative radiochemotherapy of malignant head-neck tumors].
    Heib C; Schmidt HJ; Heib T; Lüer B; Stasche N
    Laryngorhinootologie; 2001 May; 80(5):249-52. PubMed ID: 11417246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
    Francis N
    Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palmar-plantar erythrodysaesthesia syndrome due to 5-fluorouracil therapy--an underestimated toxic event?
    Iurlo A; Fornier M; Caldiera S; Bertoni F; Foa P
    Acta Oncol; 1997; 36(6):653-4. PubMed ID: 9408159
    [No Abstract]   [Full Text] [Related]  

  • 38. Mucositis and Cardiotoxicity Due to 5-Fluorouracil.
    Phillips E; France A; Thatvihane G; Nnaemeka U; Zaidi S
    Am J Ther; 2018; 25(6):e712-e714. PubMed ID: 29762143
    [No Abstract]   [Full Text] [Related]  

  • 39. [5-Fluorouracil-induced small bowel toxicity in a patient with colorectal cancer].
    Llorca Ferrándiz C; Esquerdo Galiana G; Cervera Grau JM; Briceño García HC; Calduch Broseta JV; Del Pino Cuadrado J
    Clin Transl Oncol; 2005 Sep; 7(8):356-7. PubMed ID: 16185605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug therapy of cardiogenic shock. Improvement in hemodynamics is essential].
    Stiefelhagen P
    Med Monatsschr Pharm; 2010 Aug; 33(8):303-5. PubMed ID: 21189650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.